Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Association of GLP-1 receptor agonists versus bariatric surgery with outcomes in obese patients with hypertrophic cardiomyopathy: a multicenter propensity-matched analysis2026 · 3 citations
2. 2The effect of glucagon‐like peptide‐1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta‐analysis2024 · 20 citations
3. 3Obesity and its Association to Phenotype and Clinical Course in Hypertrophic Cardiomyopathy2013 · 179 citations
4. 4A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity2012 · 255 citations
5. 5The effects of bariatric surgery on cardiac function: a systematic review and meta-analysis2023 · 51 citations